Cong-Yi Wang Selected Research

aloperine

1/2022	Aloperine Ameliorates IMQ-Induced Psoriasis by Attenuating Th17 Differentiation and Facilitating Their Conversion to Treg.
1/2017	Aloperine Protects Mice against DSS-Induced Colitis by PP2A-Mediated PI3K/Akt/mTOR Signaling Suppression.
3/2016	Aloperine Protects Mice against Ischemia-Reperfusion (IR)-Induced Renal Injury by Regulating PI3K/AKT/mTOR Signaling and AP-1 Activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cong-Yi Wang Research Topics

Disease

14	Neoplasms (Cancer) 04/2022 - 12/2004
12	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 08/2004
10	Inflammation (Inflammations) 01/2022 - 12/2008
6	Obesity 01/2022 - 06/2008
5	Insulin Resistance 01/2022 - 06/2008
5	Asthma (Bronchial Asthma) 01/2022 - 12/2013
5	Body Weight (Weight, Body) 01/2017 - 01/2005
5	Hypertension (High Blood Pressure) 01/2013 - 01/2005
4	Type 2 Diabetes Mellitus (MODY) 04/2022 - 01/2012
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 01/2016
4	5 Insulin-Dependent Diabetes Mellitus 01/2017 - 08/2004
4	Hyperglycemia 03/2013 - 06/2008
3	Colitis 01/2022 - 01/2015
3	COVID-19 04/2021 - 11/2020
3	Fibrosis (Cirrhosis) 01/2021 - 01/2014
3	Hypoxia (Hypoxemia) 02/2020 - 05/2004
3	Wounds and Injuries (Trauma) 01/2020 - 01/2016
2	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 04/2005
2	Cataract (Cataracts) 01/2022 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 04/2021 - 06/2015
2	Shock 01/2021 - 01/2016
2	Infections 11/2020 - 01/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2020 - 01/2020
2	Chronic Renal Insufficiency 08/2017 - 01/2014
2	Idiopathic Pulmonary Fibrosis 01/2017 - 01/2016
2	Ischemia 03/2016 - 08/2005
2	Acute Kidney Injury (Acute Renal Failure) 03/2016 - 12/2004
2	Hyperplasia 12/2013 - 06/2008
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2013 - 09/2009
2	Carcinogenesis 01/2013 - 01/2012
2	Hyperuricemia 10/2009 - 09/2008
1	Chronic Disease (Chronic Diseases) 04/2022
1	Chronic Bronchitis 04/2022
1	Emphysema 04/2022
1	Atherosclerosis 04/2022
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Erythema 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Capsule Opacification 01/2022
1	Diabetes Mellitus 01/2022
1	Skin Diseases (Skin Disease) 01/2022
1	Persistent Infection 09/2021
1	Communicable Diseases (Infectious Diseases) 04/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2021
1	Systemic Scleroderma (Systemic Sclerosis) 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Lung Injury 01/2021
1	Septic Shock (Toxic Shock Syndrome) 01/2021

Drug/Important Bio-Agent (IBA)

7	HMGB1 Protein (HMG1)IBA 01/2020 - 07/2008
6	Proteins (Proteins, Gene)FDA Link 09/2021 - 12/2008
6	Insulin (Novolin)FDA Link 04/2021 - 06/2008
5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2016
5	Cisplatin (Platino)FDA LinkGeneric 05/2009 - 05/2004
4	CytokinesIBA 01/2021 - 01/2015
4	UbiquitinIBA 01/2017 - 10/2006
3	Biological ProductsIBA 04/2022 - 01/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 08/2004
3	aloperineIBA 01/2022 - 03/2016
3	Small Interfering RNA (siRNA)IBA 01/2021 - 11/2017
3	Pharmaceutical PreparationsIBA 11/2019 - 01/2014
3	Triglycerides (Triacylglycerol)IBA 03/2009 - 06/2008
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 08/2005
2	Therapeutic UsesIBA 01/2022 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2017
2	SmokeIBA 10/2020 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 12/2017 - 12/2013
2	OvalbuminIBA 12/2017 - 11/2017
2	Transcription Factor CHOPIBA 12/2017 - 01/2016
2	MicroRNAs (MicroRNA)IBA 11/2017 - 09/2012
2	AlarminsIBA 10/2017 - 09/2009
2	AntigensIBA 11/2012 - 10/2010
2	AutoantigensIBA 01/2012 - 09/2009
2	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 03/2009 - 04/2006
2	Clofibrate FDA Link 10/2008 - 04/2006
2	SodiumIBA 10/2008 - 04/2006
1	Imiquimod (Aldara)FDA LinkGeneric 01/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2022
1	Pancreatitis-Associated ProteinsIBA 01/2022
1	KynurenineIBA 01/2022
1	Vitamin B 6IBA 01/2022
1	HexokinaseIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Amino Acids FDA Link 01/2022
1	AllergensIBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 09/2021
1	VaccinesIBA 04/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	HLA-DR Antigens (HLA-DR)IBA 01/2021
1	entacapone (Comtan)FDA Link 01/2021
1	Liposomes (Liposome)IBA 01/2021
1	N-methyladenosineIBA 01/2021
1	interleukin 20 (IL-20)IBA 01/2021
1	InflammasomesIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 11/2020
1	C-Reactive ProteinIBA 11/2020
1	Indicators and Reagents (Reagents)IBA 11/2020

Therapy/Procedure

12	Therapeutics 01/2022 - 12/2004
2	Drug Therapy (Chemotherapy) 06/2008 - 05/2007
1	Intraocular Lenses (Intraocular Lens) 01/2022
1	Transplantation 01/2022